RecruitingPhase not listedNCT07779460
A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
Sponsor: Novartis Pharmaceuticals
East Hanover, NJ
3 recruiting multiple sclerosis studies with a site in East Hanover, NJ.
All trials in East Hanover, NJ · All Multiple Sclerosis trials
Sponsor: Novartis Pharmaceuticals
East Hanover, NJ
Sponsor: Kessler Foundation
East Hanover, NJ
Sponsor: Kessler Foundation
East Hanover, NJ
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.